Invention Grant
- Patent Title: Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
-
Application No.: US16180854Application Date: 2018-11-05
-
Publication No.: US10597452B2Publication Date: 2020-03-24
- Inventor: Kevin Peters , Michael Allen Flynn
- Applicant: AERPIO THERAPEUTICS LLC
- Applicant Address: US OH Cincinnati
- Assignee: AERPIO PHARMACEUTICALS, INC.
- Current Assignee: AERPIO PHARMACEUTICALS, INC.
- Current Assignee Address: US OH Cincinnati
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; C07K16/22
Abstract:
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Public/Granted literature
- US20190077863A1 HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) Public/Granted day:2019-03-14
Information query
